RT @JagChhatwal: 2 in 3 people think that cost-effectiveness models should always be open source. We need to create incentives for develope…
RT @JagChhatwal: 2 in 3 people think that cost-effectiveness models should always be open source. We need to create incentives for develope…
RT @JagChhatwal: 2 in 3 people think that cost-effectiveness models should always be open source. We need to create incentives for develope…
RT @JagChhatwal: 2 in 3 people think that cost-effectiveness models should always be open source. We need to create incentives for develope…
RT @JagChhatwal: 2 in 3 people think that cost-effectiveness models should always be open source. We need to create incentives for develope…
RT @JagChhatwal: 2 in 3 people think that cost-effectiveness models should always be open source. We need to create incentives for develope…
RT @JagChhatwal: 2 in 3 people think that cost-effectiveness models should always be open source. We need to create incentives for develope…
A factor promotion letter writers could consider, perhaps. Would love hear about other ways to create incentives for open source simulation models
2 in 3 people think that cost-effectiveness models should always be open source. We need to create incentives for developers to make them open source... https://t.co/6XP9vprvNW https://t.co/a4KtGyabpE https://t.co/jp5XJ5ZjZE @PeterNeumann11 @AnkurFactoria
An interesting debate emerged in Pharmacoeconomics re: conducting underlying value assessment analysis using open source methods. IVI supports open source while others write that using an open source approach inhibits model development. What do you think?
RT @kchalkidou: Developing Open-Source Models for the US System: “the feedback from US decision makers has been limited; the interest has b…
RT @kchalkidou: Developing Open-Source Models for the US System: “the feedback from US decision makers has been limited; the interest has b…
Developing Open-Source Models for the US System: “the feedback from US decision makers has been limited; the interest has been less than what we anticipated at the start” LMIC policy makers may be more interested than US ones?! @idsihealth https://t.co/0
#HealthEconJA Developing Open-Source Models for the US Health System: Practical Experiences and Challenges to Date with the Open-Source Value Project https://t.co/RHGIuWsURI